Jaina, Adryll R.
HRN: 23-83-88 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/18/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
04/18/2025
04/24/2025
IV
4ml
TID
AGE
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes